• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌患者恶性与良性胸腔积液的鉴别:一项F-FDG PET/CT回顾性研究。

Differentiating malignant and benign pleural effusion in patients with lung cancer: an F-FDG PET/CT retrospectively study.

作者信息

Zhang Weishan, Liu Zhe, Duan Xiaoyi, Li Yan, Shen Cong, Guo Youmin, Yang Jian

机构信息

PET/CT Department of the First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Radiology Department of the First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

出版信息

Front Oncol. 2023 Jun 30;13:1192870. doi: 10.3389/fonc.2023.1192870. eCollection 2023.

DOI:10.3389/fonc.2023.1192870
PMID:37456249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10348711/
Abstract

RATIONALE

To explore the clinical role of F-fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT) in differentiating malignant pleural effusion (MPE) from benign pleural effusion (BPE) in patients with lung cancer.

METHODS

Over a 8-year period, we retrospectively reviewed PET/CT data of lung cancer patients with pleural effusion, with 237 participants enrolled for analysis. The nature of pleural effusion was confirmed using pleural cytology or biopsy. MPE versus BPE comparison and multiple regression analysis were performed. Receiver operating characteristic (ROC) curve analysis was used for evaluating the diagnostic performance.

RESULTS

Of the 237 participants, 170 had MPEs and 67 had BPEs. Compared with BPEs, MPEs had higher pleural SUVmax and thicker pleura and were more common among non-small cell lung cancers, peripheral tumors, and women (p < 0.05). BPEs had larger and higher F-FDG uptake thoracic lymph nodes and more complications of pneumonia (p < 0.05) than MPEs. Multiple regression analysis was used to identify the pleural SUVmax (odds ratio, OR = 38.8), sex (OR = 0.033), and mediastinal lymphoid node size (OR = 0.86) as independent risk factors for MPEs. The sensitivity, specificity, and area under the ROC curve (AUC) in the combined ROC curve analysis by using the three factors were 95.3%, 95.5%, and 0.989, respectively.

CONCLUSION

F-FDG PET/CT integrated imaging is an effective non-invasive method for differential diagnosis of MPE in patients with lung cancer. Pleural SUVmax combined with thoracic lymph nodes and sex has high diagnostic value.

摘要

原理

探讨¹⁸F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(¹⁸F-FDG PET/CT)在肺癌患者中鉴别恶性胸腔积液(MPE)与良性胸腔积液(BPE)的临床作用。

方法

在8年期间,我们回顾性分析了肺癌伴胸腔积液患者的PET/CT数据,纳入237例参与者进行分析。通过胸腔细胞学检查或活检确定胸腔积液的性质。进行MPE与BPE的比较及多元回归分析。采用受试者操作特征(ROC)曲线分析评估诊断性能。

结果

237例参与者中,170例为MPE,67例为BPE。与BPE相比,MPE的胸腔SUVmax更高、胸膜更厚,在非小细胞肺癌、周围型肿瘤和女性中更常见(p<0.05)。BPE的¹⁸F-FDG摄取的胸部淋巴结更大、更多,且肺炎并发症比MPE更多(p<0.05)。多元回归分析确定胸腔SUVmax(比值比,OR = 38.8)、性别(OR = 0.033)和纵隔淋巴结大小(OR = 0.86)为MPE的独立危险因素。使用这三个因素进行联合ROC曲线分析时,敏感性、特异性和ROC曲线下面积(AUC)分别为95.3%、95.5%和0.989。

结论

¹⁸F-FDG PET/CT融合成像对于肺癌患者MPE的鉴别诊断是一种有效的非侵入性方法。胸腔SUVmax联合胸部淋巴结及性别具有较高的诊断价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a87/10348711/13139b7f9d87/fonc-13-1192870-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a87/10348711/f9896f6f7b40/fonc-13-1192870-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a87/10348711/13139b7f9d87/fonc-13-1192870-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a87/10348711/f9896f6f7b40/fonc-13-1192870-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a87/10348711/13139b7f9d87/fonc-13-1192870-g002.jpg

相似文献

1
Differentiating malignant and benign pleural effusion in patients with lung cancer: an F-FDG PET/CT retrospectively study.肺癌患者恶性与良性胸腔积液的鉴别:一项F-FDG PET/CT回顾性研究。
Front Oncol. 2023 Jun 30;13:1192870. doi: 10.3389/fonc.2023.1192870. eCollection 2023.
2
Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.F-18 FDG PET/CT对非小细胞肺癌患者恶性胸腔积液的预测价值
Onkologie. 2011;34(6):298-303. doi: 10.1159/000328793. Epub 2011 May 20.
3
Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.开发和验证用于诊断恶性胸腔积液的 PET-CT 评分。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1457-1467. doi: 10.1007/s00259-019-04287-7. Epub 2019 Mar 22.
4
Can PET/CT be used more effectively in pleural effusion evaluation?PET/CT 在胸腔积液评估中能否更有效地使用?
Jpn J Radiol. 2021 Dec;39(12):1186-1194. doi: 10.1007/s11604-021-01155-z. Epub 2021 Jun 24.
5
Lymph nodes rather than pleural metabolic activity in F-FDG PET/CT correlates with malignant pleural effusion recurrence in advanced non-small cell lung cancer.在晚期非小细胞肺癌中,F-FDG PET/CT检查显示的是淋巴结而非胸膜的代谢活性与恶性胸腔积液复发相关。
Transl Lung Cancer Res. 2024 Sep 30;13(9):2236-2253. doi: 10.21037/tlcr-24-291. Epub 2024 Sep 25.
6
[Clinical role of F-18 FDG PET/CT in differentiating malignant and benign pleural effusion in patients with lung cancer].[F-18 FDG PET/CT在肺癌患者恶性与良性胸腔积液鉴别诊断中的临床作用]
Zhongguo Fei Ai Za Zhi. 2012 Nov;15(11):652-5. doi: 10.3779/j.issn.1009-3419.2012.11.08.
7
The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.18F-FDG PET/CT融合成像在鉴别恶性与良性胸腔积液中的作用
PLoS One. 2016 Aug 25;11(8):e0161764. doi: 10.1371/journal.pone.0161764. eCollection 2016.
8
Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on F-FDG PET/CT.基于F-FDG PET/CT预测肺腺癌患者胸腔积液的性质
EJNMMI Res. 2021 Oct 15;11(1):108. doi: 10.1186/s13550-021-00850-2.
9
[Value of PET/MRI in the diagnosis of malignant pleural effusion in comparison with PET/CT].[PET/MRI与PET/CT相比在恶性胸腔积液诊断中的价值]
Zhonghua Yi Xue Za Zhi. 2021 Aug 10;101(30):2363-2369. doi: 10.3760/cma.j.cn112137-20210516-01142.
10
Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.1,230 例患者中六种肿瘤标志物对恶性胸腔积液的诊断价值:一项单中心回顾性研究。
Pathol Oncol Res. 2022 Apr 20;28:1610280. doi: 10.3389/pore.2022.1610280. eCollection 2022.

本文引用的文献

1
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
2
Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on F-FDG PET/CT.基于F-FDG PET/CT预测肺腺癌患者胸腔积液的性质
EJNMMI Res. 2021 Oct 15;11(1):108. doi: 10.1186/s13550-021-00850-2.
3
Diagnosis of Malignant Pleural Effusion Using CT Scan and Pleural-Fluid Cytology Together. A Preliminary Case-Control Study.CT 扫描与胸腔积液细胞学检查联合用于恶性胸腔积液的诊断。一项初步的病例对照研究。
Anticancer Res. 2020 Feb;40(2):1135-1139. doi: 10.21873/anticanres.14054.
4
Current perspective on the diagnosis of malignant pleural effusion.恶性胸腔积液诊断的当前观点
J Thorac Dis. 2019 May;11(Suppl 9):S1234-S1236. doi: 10.21037/jtd.2019.02.64.
5
CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion.CBLL1 在非小细胞肺癌中高表达,促进细胞增殖和侵袭。
Thorac Cancer. 2019 Jun;10(6):1479-1488. doi: 10.1111/1759-7714.13097. Epub 2019 May 23.
6
Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.开发和验证用于诊断恶性胸腔积液的 PET-CT 评分。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1457-1467. doi: 10.1007/s00259-019-04287-7. Epub 2019 Mar 22.
7
Estrogen-related receptor alpha triggers the proliferation and migration of human non-small cell lung cancer via interleukin-6.雌激素相关受体α通过白细胞介素 6 触发人非小细胞肺癌的增殖和迁移。
Cell Biochem Funct. 2018 Jul;36(5):255-262. doi: 10.1002/cbf.3337. Epub 2018 Jun 3.
8
Long-term outcome of patients with nonspecific pleurisy at medical thoracoscopy.非特异性胸膜炎患者经内科胸腔镜检查后的长期预后
Respir Med. 2017 Mar;124:1-5. doi: 10.1016/j.rmed.2017.01.005. Epub 2017 Jan 23.
9
The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.18F-FDG PET/CT融合成像在鉴别恶性与良性胸腔积液中的作用
PLoS One. 2016 Aug 25;11(8):e0161764. doi: 10.1371/journal.pone.0161764. eCollection 2016.
10
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.IASLC 肺癌分期项目:对即将发布的(第八版)肺癌 TNM 分类中 TNM 分期分组的修订建议。
J Thorac Oncol. 2016 Jan;11(1):39-51. doi: 10.1016/j.jtho.2015.09.009.